Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
828 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Surgical | 29.09 | NA | 877 | 4,326 | 877 | ||||||||||||
827 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Surgical | 46.80 | NA | 1,411 | 7,324 | 1,398 | ||||||||||||
826 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Surgical | 24.11 | NA | 727 | 3,787 | 649 |
DEMOGRAPHIC DETAILS OF DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
Race | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|
White | 765 | 87.23 |
Black | 65 | 7.41 |
Unknown | 20 | 2.28 |
Age Group ( Years ) | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|
65 to 69 | 296 | 33.75 |
70 to 74 | 232 | 26.45 |
75 to 79 | 143 | 16.31 |
TOP ICD DIAGNOSIS CODES FOR DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|---|
C7A8 | Other malignant neuroendocrine tumors | 174 | 19.84 |
C480 | Malignant neoplasm of retroperitoneum | 106 | 12.09 |
C7B8 | Other secondary neuroendocrine tumors | 95 | 10.83 |
TOP ICD PROCEDURE CODES FOR DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|---|
07T20ZZ | Resection of Left Neck Lymphatic, Open Approach | 112 | 12.77 |
07T10ZZ | Resection of Right Neck Lymphatic, Open Approach | 109 | 12.43 |
0WBH0ZZ | Excision of Retroperitoneum, Open Approach | 74 | 8.44 |
TOP HOSPITALS ASSOCIATED WITH DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|---|---|---|---|
University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 23 | 2.62 |
Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 16 | 1.82 |
University of Alabama Hospital | 619 19TH ST S | Birmingham | AL | 35249 | 15 | 1.71 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|---|---|---|---|
DR. JOHN DAVID CHRISTEIN | 619 19TH ST S | BIRMINGHAM | AL | 35249 | NA | NA |
DR. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | NA | NA |
DR. SCOTT J STERN | 8901 CARTI WAY | LITTLE ROCK | AR | 72205 | NA | NA |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
---|---|---|---|---|---|---|
DR. JOHN DAVID CHRISTEIN | 619 19TH ST S | BIRMINGHAM | AL | 35249 | NA | NA |
DR. SCOTT ALAN MCLEAN | 1500 E MEDICAL CENTER DR | ANN ARBOR | MI | 48109 | NA | NA |
DR. SCOTT J STERN | 8901 CARTI WAY | LITTLE ROCK | AR | 72205 | NA | NA |
DRG 828: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2017 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2017 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2017 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | I10 | Essential (primary) hypertension | 1,109 | 503 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | E785 | Hyperlipidemia, unspecified | 522 | 294 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | C7989 | Secondary malignant neoplasm of other specified sites | 650 | 270 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Z87891 | Personal history of nicotine dependence | 510 | 242 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | K219 | Gastro-esophageal reflux disease without esophagitis | 586 | 224 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | C7A8 | Other malignant neuroendocrine tumors | 446 | 174 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Z7982 | Long term (current) use of aspirin | 191 | 136 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | E119 | Type 2 diabetes mellitus without complications | 357 | 130 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | Z79899 | Other long term (current) drug therapy | 399 | 114 | |||||||||||||||||
General Surgery | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedure | I2510 | Atherosclerotic heart disease of native coronary artery without angina pectoris | 174 | 112 |